Skip to content

Mirum Pharmaceuticals, Inc. MIRM Compensation and benefits

Compensation and benefits at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Roivant Sciences logo
Roivant SciencesROIV
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s compensation and benefits?
Mirum Pharmaceuticals, Inc. (MIRM) reported compensation and benefits of $35.43M in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s compensation and benefits changed year-over-year?
Mirum Pharmaceuticals, Inc.'s compensation and benefits increased by 113.5% year-over-year, from $16.6M to $35.43M.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s compensation and benefits?
Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s compensation and benefits has grown at a 50.3% compound annual growth rate (CAGR), from $20.94M to $47.28M.